EX-21.1 4 exhibit211-2022q4.htm EX-21.1

Exhibit 21.1

Subsidiaries

Name of Subsidiary						Jurisdiction of Incorporation or Organization						Percentage of Ownership by the Registrant
B10 Health Technologies Private Limited						India						100		%
BeiGene 101						Cayman Islands						100		%
BeiGene AUS Pty Ltd						Australia						100		%
BeiGene Austria GmbH						Austria						100		%
BeiGene (Beijing) Co., Ltd.						People’s Republic of China						100		%
BeiGene Biologics Co., Ltd.						People’s Republic of China						100		%
BeiGene Brasil Ltda.						Brazil						100		%
BeiGene (Canada) ULC						Canada						100		%
BeiGene Colombia S.A.S.						Colombia						100		%
BeiGene ESP, S.L.						Spain						100		%
BeiGene France Sarl						France						100		%
BeiGene Germany GmbH						Germany						100		%
BeiGene Guangzhou Biologics Manufacturing Co., Ltd.						People’s Republic of China						100		%
BeiGene (Guangzhou) Innovation Technology Co., Ltd.						People’s Republic of China						100		%
BeiGene (Hong Kong) Co., Limited						Hong Kong						100		%
BeiGene Hopewell Urban Renewal, LLC						New Jersey, United States						100		%
BeiGene International GmbH						Switzerland						100		%
BeiGene Ireland Limited						Republic of Ireland						100		%
BeiGene (Italy) S.r.l.						Italy						100		%
BeiGene Japan GK						Japan						100		%
BeiGene Korea Y.H.						South Korea						100		%
BeiGene Netherlands B.V.						Netherlands						100		%
BeiGene NZ Unlimited						New Zealand						100		%
BeiGene Pharmaceuticals GmbH						Switzerland						100		%
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd.						People’s Republic of China						100		%
BeiGene Pharmaceuticals Israel Ltd.						Israel						100		%
BeiGene Pharmaceutical (Shanghai) Co., Ltd.						People’s Republic of China						100		%
BeiGene Poland sp. z o.o.						Poland						100		%
BeiGene Shanghai						Cayman Islands						100		%
BeiGene Shanghai 101						Cayman Islands						100		%
BeiGene (Shanghai) Co., Ltd.						People’s Republic of China						100		%
BeiGene (Shanghai) Management Consulting Co., Ltd.						People’s Republic of China						100		%
BeiGene (Shanghai) Research & Development Co., Ltd.						People’s Republic of China						100		%
BeiGene Singapore Pte. Ltd.						Singapore						100		%
BeiGene South Africa Pty Ltd.						South Africa						100		%
BeiGene (Suzhou) Co., Ltd.						People’s Republic of China						100		%
BeiGene Sweden AB						Sweden						100		%
BeiGene Switzerland GmbH						Switzerland						100		%
BeiGene (Taiwan) Limited						Taiwan						100		%
BeiGene (Thailand) Ltd.						Thailand						100		%
BeiGene Turkey Medical Products Trade Limited Company						Turkey						100		%
BeiGene UK, Ltd.						United Kingdom						100		%
BeiGene United Kingdom, Ltd.						United Kingdom						100		%
BeiGene USA, Inc.						Delaware, United States						100		%

---

Exhibit 21.1

BeiGene US Holdings, LLC						Delaware, United States						100		%
BeiGene US Manufacturing Co., Inc.						Delaware, United States						100		%
Beijing Innerway Bio-tech Co., Ltd.						People’s Republic of China						100		%
Newco 101						Cayman Islands						100		%
Pi Health Brasil Consultoria Ltda.						Brazil						100		%
Pi Health Hong Kong Limited						Hong Kong						100		%
Pi Health, Ltd.						Cayman Islands						100		%
Pi Health USA, LLC						Delaware, United States						100		%
SuGene Pharmaceuticals (Suzhou) Co., Ltd.						People’s Republic of China						100		%